Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A two-step mechanism governing PARP1-DNA retention by PARP inhibitors
Huijun Xue, Amit Bhardwaj, Yandong Yin, et al.
Science Advances (2022) Vol. 8, Iss. 36
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Single-molecule analysis of DNA-binding proteins from nuclear extracts (SMADNE)
Matthew A. Schaich, Brittani L Schnable, Namrata Kumar, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 7, pp. e39-e39
Open Access | Times Cited: 31
Clinical PARP inhibitors allosterically induce PARP2 retention on DNA
Marie-France Langelier, Xiaohui Lin, Shan Zha, et al.
Science Advances (2023) Vol. 9, Iss. 12
Open Access | Times Cited: 30
ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification
Élise Rouleau-Turcotte, John M. Pascal
Journal of Biological Chemistry (2023) Vol. 299, Iss. 12, pp. 105397-105397
Open Access | Times Cited: 23
FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells
Ke Cong, Nathan J. MacGilvary, Silviana Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells
Petar-Bogomil Kanev, Sylvia Varhoshkova, Irina Georgieva, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114234-114234
Open Access | Times Cited: 10
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 8
The dynamics and regulation of PARP1 and PARP2 in response to DNA damage and during replication
Hanwen Zhang, Shan Zha
DNA repair (2024) Vol. 140, pp. 103690-103690
Closed Access | Times Cited: 8
Human PARP1 substrates and regulators of its catalytic activity: An updated overview
Tao Zhu, Juyan Zheng, Lingling Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Advances in PARP Inhibitors for Prostate Cancer
Steven Tisseverasinghe, Boris Bahoric, Maurice Anidjar, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1849-1849
Open Access | Times Cited: 18
PARP trapping is governed by the PARP inhibitor dissociation rate constant
Angelica A. Gopal, Bianca Fernandez, Justin Delano, et al.
Cell chemical biology (2024) Vol. 31, Iss. 7, pp. 1373-1382.e10
Closed Access | Times Cited: 7
Sequential requirements for distinct Polθ domains during theta-mediated end joining
Carel Fijen, Lea Drogalis Beckham, Dante Terino, et al.
Molecular Cell (2024) Vol. 84, Iss. 8, pp. 1460-1474.e6
Closed Access | Times Cited: 6
The potential of PARP inhibitors in targeted cancer therapy and immunotherapy
Jaromir Hunia, Karol Gawalski, Aleksandra Szredzka, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 23
Telomere-related DNA damage response pathways in cancer therapy: prospective targets
Liting Gu, Mingdi Liu, Yuning Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Positioning Loss of PARP1 Activity as the Central Toxic Event in BRCA-Deficient Cancer
Nathan J. MacGilvary, Sharon B. Cantor
DNA repair (2024) Vol. 144, pp. 103775-103775
Open Access | Times Cited: 4
Single-molecule studies of repair proteins in base excision repair
Donghun Lee, Gwangrog Lee
BMB Reports (2025) Vol. 58, Iss. 1, pp. 17-23
Open Access
Single-molecule analysis of PARP1-G-quadruplex interaction
Paras Gaur, Fletcher E. Bain, Riaz Meah, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Poly(ADP-ribose) polymerase inhibitors in cancer therapy
Zi-Qi Zhu, Yujun Shi
Chinese Medical Journal (2025)
Open Access
Duplexed CeTEAM drug biosensors reveal determinants of PARP inhibitor selectivity in cells
Maria João Pires, Seher Alam, Alen Lovrić, et al.
Journal of Biological Chemistry (2025), pp. 108361-108361
Open Access
Empowering PARP inhibition through rational combination: Mechanisms of PARP inhibitors and combinations with a focus on the treatment of metastatic castration-resistant prostate cancer
Jinge Zhao, Bo Tang, Pengfei Shen, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104698-104698
Closed Access
BRCA2 prevents PARPi-mediated PARP1 retention to protect RAD51 filaments
Sudipta Lahiri, George L. Hamilton, Gemma Moore, et al.
Nature (2025)
Closed Access
Engaging an engineered PARP-2 catalytic domain mutant to solve the complex structures harboring approved drugs for structure analyses
Xiaoyu Wang, Jie Zhou, Bailing Xu
Bioorganic Chemistry (2025), pp. 108471-108471
Closed Access
Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma
Xin Peng, Xin Huang, Shaolu Zhang, et al.
Advanced Science (2024) Vol. 11, Iss. 30
Open Access | Times Cited: 3
Poly ADP-ribose signaling is dysregulated in Huntington disease
Tamara Maiuri, Carlos Barba Bazan, Rachel Harding, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 40
Closed Access | Times Cited: 3
Blocking the Self‐Destruct Program of Dopamine Neurons through Macrophage Migration Inhibitory Factor Nuclease Inhibition
Jaimin Patel, Valina L. Dawson, Ted M. Dawson
Movement Disorders (2024) Vol. 39, Iss. 4, pp. 644-650
Closed Access | Times Cited: 2
CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos
Rita Sala, Hector Esquer, Timothy Kellett, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8590-8590
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top